Motofen (Sebela Pharmaceuticals Inc.)


Welcome to the PulseAid listing for the Motofen drug offered from Sebela Pharmaceuticals Inc.. This Anticholinergic [EPC],Cholinergic Antagonists [MoA],Cholinergic Muscarinic Antagonist [EPC],Cholinergic Muscarinic Antagonists [MoA],Antidiarrheal [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Sebela Pharmaceuticals Inc.
NON-PROPRIETARY NAME: difenoxin and atropine sulfate
SUBSTANCE NAME: ATROPINE SULFATE; DIFENOXIN HYDROCHLORIDE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Anticholinergic [EPC],Cholinergic Antagonists [MoA],Cholinergic Muscarinic Antagonist [EPC],Cholinergic Muscarinic Antagonists [MoA],Antidiarrheal [EPC]
ROUTE: ORAL
DOSAGE FORM: TABLET
MARKETING CATEGORY NAME: NDA
START MARKETING DATE: 2017-04-11
END MARKETING DATE: 0000-00-00


Motofen HUMAN PRESCRIPTION DRUG Details:

Item DescriptionMotofen from Sebela Pharmaceuticals Inc.
LABELER NAME: Sebela Pharmaceuticals Inc.
DEA SCHEDULE: CIV
ACTIVE STRENGTH: .025; 1(mg/1; mg/1)
START MARKETING DATE: 2017-04-11
END MARKETING DATE: 0000-00-00
PRODUCT ID: 54766-200_4cd3f029-a5e4-5812-e054-00144ff8d46c
PRODUCT NDC: 54766-200
APPLICATION NUMBER: NDA017744

Other ATROPINE SULFATE; DIFENOXIN HYDROCHLORIDE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Sebela Pharmaceuticals Inc.Motofen